Fish Mislabeling a Common Problem

A new study says that more than one-third of fish sold at stores and restaurants in New York City is mislabeled.

Researchers with the conservation group Oceana conducted DNA tests on 150 samples of fresh fish from 81 establishments in the city and found that 39 percent of them were mislabeled, The New York Times reported.

In some cases, cheaper types of fish were labeled as more expensive types of fish. The study also identified public health concerns. For example, 13 types of fish, including tilefish, were identified as red snapper. Mercury levels in tilefish are so high that the U.S. Food and Drug Administration says that this type of fish should not be eaten by pregnant or nursing women and young children.

The researchers also found that 94 percent of fish sold as white tuna was not tuna at all. In many cases it was actually a fish known as snake mackerel, or escolar, which contains a toxin that can cause severe diarrhea if a person eats more than a few ounces of the fish, The Times reported.

These new findings are similar to previous studies conducted by Oceana in Los Angeles, Boston and Miami, where 55, 48 and 31 percent of fish samples, respectively, were mislabeled.

Source: U.S. Department of Health & Human Services

Thai Dessert

Steamed Pandan Cake

The cake has two layers.

The bottom green layer is made with rice flour mixed with mung bean flour, juice of pandan leaves, sugar and coconut milk. The ingredients of the top white layer are rice flour, coconut cream and salt.

You can buy these cakes from street vendors in Thailand.

Workout Anywhere – Chest Stretch

Stretching the Chest in a Doorway

  1. Standing beside the door, place one forearm on the frame at roughly chest height. Your arm should be bent at a 90º angle.
  2. Turn your body gently away from the arm so you feel a slight stretch in your chest and shoulders. Hold for 30 seconds.
  3. Switch and repeat on the opposite arm.

Source: The Globe and Mail

Drug Shows Promise in Prostate Cancer Spread to Bone

A new drug demonstrated dramatic and rapid effects on prostate cancer that had spread to the bone, according to a study reported by University of Michigan Comprehensive Cancer Center researchers.

About two-thirds of patients treated with cabozantinib had improvements on their bone scans, with 12 percent seeing complete resolution of uptake on bone scan. Bone scans assess the degree to which cancer is in the bone; improvements on these scans suggest a response to the drug.

“The effects of cabozantinib on bone scans are unprecedented in the treatment of prostate cancer,” says lead study author David C. Smith, M.D., professor of internal medicine and urology at the University of Michigan Medical School.

Cabozantinib is designed to target two important pathways linked to the growth and spread of prostate cancer. The drug had the most effect on tumors that had spread to the bone, which is the major site where prostate cancer spreads. These tumors are typically very challenging to treat once they become resistant to hormone-based therapies.

In addition to the improvements on bone scans, 67 percent of patients with bone pain reported an improvement in pain control and 56 percent decreased or eliminated narcotic painkillers after treatment with cabozantinib. Results of the study appear in the Journal of Clinical Oncology.

The trial enrolled 171 men with castration-resistant prostate cancer, meaning their tumors no longer responded to hormone-based therapies. The study began as a randomized trial in which all patients received cabozantinib for 12 weeks, after which patients were randomized to receive continued cabozantinib or placebo. The randomization was stopped early because of the dramatic effects on bone scan, and because patients receiving placebo saw their cancer progress much more quickly than those that remained on drug.

Among the 31 patients who were randomized, cancer progressed after a median 23.9 weeks for patients taking cabozantinib, compared with 5.9 weeks for patients on placebo.

“Discontinuing randomization is not common. Stabilization of disease in advanced prostate cancer is rarely due to the natural history of the disease and is in this case due to drug effect,” Smith says.

“While these initial results are promising, we are still uncertain how cabozantinib will impact the gold standard of survival,” he adds.

Phase III studies have begun at some institutions, and U-M researchers are conducting a phase II study to better understand the effect cabozantinib has on bone. This drug is not offered routinely in clinical care at this time.

Source: University of Michigan Health System

Cuttlefish Appetizer


10 oz mini cuttlefish
25 g butter
2 cloves garlic, cut into slices
1/2 onion, diced
1/2 green bell pepper, diced
1 tsp ground black pepper


1 tbsp light soy sauce
1 tsp dark soy sauce
1 tsp Worcestershire sauce
1 tsp sugar
1 tbsp water


  1. Blanch cuttlefish in boiling water. Drain and pat dry with paper towel.
  2. Melt butter and some oil in a wok. Sauté garlic, onion and bell pepper. Mix in black pepper. Toss briefly.
  3. Add seasoning and cuttlefish. Stir-fry until sauce boils and thickens. Serve hot.

Source: Hong Kong magazine

Today’s Comic